Valuation: Curiosis, Inc.

Market Cap 193B 129M 113M 105M 96.64M 183M 12.37B 186M 1.25B 491M 6.08B 486M 475M 20.99B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 175M 117K 103K 95.02K 87.43K 165K 11.2M 169K 1.13M 444K 5.5M 439K 430K 18.99M EV / Sales 2026 *
11.3x
EV / Sales 2027 * 7.31x
Free-Float
71.28%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week+2.01%
Current month-2.69%
1 month-7.14%
3 months-49.60%
6 months-44.47%
Current year-48.27%
1 week 23,600
Extreme 23600
27,450
1 month 22,050
Extreme 22050
34,450
Current year 22,050
Extreme 22050
88,000
1 year 22,050
Extreme 22050
96,400
3 years 22,050
Extreme 22050
96,400
5 years 22,050
Extreme 22050
96,400
10 years 22,050
Extreme 22050
96,400
Manager TitleAgeSince
Chief Executive Officer 55 2014-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 2014-12-31
Director/Board Member 53 2024-03-31
Director/Board Member 57 2016-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%+2.01% - - 129M
+0.28%+2.11%+21.54%+0.35% 196B
+0.08%-5.94%-20.49%+17.34% 144B
+0.56%+3.38%-2.29%-16.18% 142B
-0.27%+0.11%-56.73%-15.42% 66.37B
-0.46%-3.56%+17.60%-1.40% 52.85B
-3.89%-2.47%-25.24%-33.48% 45.22B
-0.19%+2.63%+8.73%+12.31% 37.86B
-0.85%-1.50%+5.76%+38.61% 36.64B
+0.94%+0.72%-13.07%-19.77% 29.71B
Average -0.72%-0.96%-7.13%-1.96% 75.1B
Weighted average by Cap. -0.51%-0.32%-3.83%-1.39%

Financials

2026 *2027 *
Net sales 15.4B 10.31M 9.04M 8.38M 7.71M 14.58M 987M 14.86M 99.85M 39.16M 485M 38.72M 37.88M 1.67B 23.9B 16M 14.04M 13M 11.96M 22.63M 1.53B 23.07M 155M 60.77M 752M 60.1M 58.78M 2.6B
Net income - -
Net Debt -18.4B -12.32M -10.81M -10.01M -9.21M -17.42M -1.18B -17.76M -119M -46.79M -579M -46.27M -45.26M -2B -18.4B -12.32M -10.81M -10.01M -9.21M -17.42M -1.18B -17.76M -119M -46.79M -579M -46.27M -45.26M -2B
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
97
Date Price Change Volume
26-07-13 ₩25,350.00 -1.17% 68,486
26-07-10 ₩25,650.00 +5.99% 47,585
26-07-09 ₩24,200.00 -4.35% 46,941
26-07-08 ₩25,300.00 -8.99% 91,126
26-07-07 ₩27,800.00 +11.87% 151,492
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock